Geoffrey Dusheiko

Geoffrey Dusheiko, is Emeritus Professor of Medicine at the Royal Free Hospital and University College London School of Medicine and Consultant Hepatologist at Kings College Hospital London, in London, UK.
Professor Dusheiko’s MBBS degree is from the University of Witwatersrand in Johannesburg, South Africa. His fellowships were conducted at the Johannesburg Hospital Liver Unit and the National Institutes of Health, Maryland, and the University of Minnesota, USA.

Professor Dusheiko’s research interests include the management and treatment of HCV and HBV and small hepatocellular carcinoma; he has a special interest in research on viral hepatitis, especially viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis and antiviral therapies.

Professor Dusheiko previously served as Educational Councilor on the Governing Board of EASL for 4 years and was the recipient of the EASL Recognition Award in 2014. An advisor for the UK National Institute of Health and Care Excellence, Professor Dusheiko is an author of the World Health Organization’s HBV guidelines and he was a Director of the Skipton Fund, a UK ex gratia payment scheme for patients infected with HCV through contaminated blood products. Professor Dusheiko served as interim Deputy Director of the Blood Safety, HIV, viral hepatitis and STI Division of Public Health England in 2019.

Professor Dusheiko is a co-editor of Alimentary Pharmacology and Therapeutics, and has previously served on editorial boards for the Journal of Viral Hepatitis, Hepatology, Best Practice & Research Clinical Gastroenterology, and Gut among others. Professor Dusheiko has authored or co-authored more than 500 articles in international peer-reviewed journals or books. Professor Dusheiko is an Honorary Professor at the University of Cape Town and was elected to Academia Europaea in 2020.